Karsten Schrör

11.2k total citations · 1 hit paper
345 papers, 8.4k citations indexed

About

Karsten Schrör is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Molecular Biology. According to data from OpenAlex, Karsten Schrör has authored 345 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Cardiology and Cardiovascular Medicine, 105 papers in Pharmacology and 74 papers in Molecular Biology. Recurrent topics in Karsten Schrör's work include Antiplatelet Therapy and Cardiovascular Diseases (107 papers), Inflammatory mediators and NSAID effects (93 papers) and Nitric Oxide and Endothelin Effects (62 papers). Karsten Schrör is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (107 papers), Inflammatory mediators and NSAID effects (93 papers) and Nitric Oxide and Endothelin Effects (62 papers). Karsten Schrör collaborates with scholars based in Germany, United States and Austria. Karsten Schrör's co-authors include Artur‐Aron Weber, Thomas Hohlfeld, Bernhard H. Rauch, Mario Sarbia, Jutta Meyer-Kirchrath, Katja Zimmermann, Kurt Huber, H. Strobach, Helmut E. Gabbert and F Borchard and has published in prestigious journals such as Circulation, Blood and Circulation Research.

In The Last Decade

Karsten Schrör

339 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cyclooxygenase-2 expression in human esophageal carcinoma.

1999 585 citations Artur‐Aron Weber, Karsten Schrör et al. PubMed profile →

Peers

Countries citing papers authored by Karsten Schrör

Since Specialization

Citations

This map shows the geographic impact of Karsten Schrör's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karsten Schrör with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karsten Schrör more than expected).

Fields of papers citing papers by Karsten Schrör

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karsten Schrör. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karsten Schrör. The network helps show where Karsten Schrör may publish in the future.

Co-authorship network of co-authors of Karsten Schrör

This figure shows the co-authorship network connecting the top 25 collaborators of Karsten Schrör. A scholar is included among the top collaborators of Karsten Schrör based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karsten Schrör. Karsten Schrör is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Can an Old Ally Defeat a New Enemy? 2020 ·Circulation ·Paul A. Gurbel, Kevin P. Bliden, Karsten Schrör	9
2	Konsensuspapier: Schlaganfallprophylaxe bei Patienten mit nichtvalvulärem Vorhofflimmern 2016 ·Herzschrittmachertherapie + Elektrophysiologie ·Thomas M. Helms, Sigmund Silber, Andreas Schäfer, Florian Masuhr, Frederick Palm, Harald Darius, Karsten Schrör, Dietmar Bänsch, Peter Bramlage, (unknown), Christoph A. Karle, Tom Stargardt, Joachim Weil, J. Christoph Geller	3
3	Factor-Xa-induced mitogenesis and migration require sphingosine kinase activity and S1P formation in human vascular smooth muscle cells 2013 ·Cardiovascular Research ·Andreas Böhm, (unknown), (unknown), Anke C. Fender, Anja Lüth, Burkhard Kleuser, Karsten Schrör, Bernhard H. Rauch	37
4	Response Variability to P2Y12 Receptor Inhibitors 2013 ·JACC: Cardiovascular Interventions ·Jolanta M. Siller‐Matula, Dietmar Trenk, Karsten Schrör, Meinrad Gawaz, Steen Dalby Kristensen, Robert F. Storey, Kurt Huber	119
5	Acetylsalicylsäure und Prävention kolorektaler Karzinome 2013 ·Der Internist ·Karsten Schrör, Bernhard H. Rauch	2
6	Neue Plättchenhemmstoffe und die Frage der dualen Hemmung 2012 ·Der Internist ·Karsten Schrör	2
7	Abstract 16950: Sphingosine-1-Phosphate is Thromboxane-dependently Released from Platelets and Modulates Chemotaxis of Human Monocytes 2010 ·Circulation ·Amin Polzin, Andreas Böhm, (unknown), A Rosenkranz, Thomas Hohlfeld, Karsten Schrör, Bernhard H. Rauch	1
8	Complex effects of different green tea catechins on human platelets 2003 ·FEBS Letters ·(unknown), (unknown), Karsten Schrör, Artur‐Aron Weber	53
9	Selective Cyclooxygenase-2 Inhibition Upregulates Renal Cortical α<sub>v</sub> Integrin Expression 2003 ·Nephron Experimental Nephrology ·(unknown), (unknown), Jutta Meyer-Kirchrath, Karsten Schrör, B. Grabensee, Peter Heering	5
10	COX‐2 inhibition and prostaglandin receptors in experimental nephritis 2003 ·European Journal of Clinical Investigation ·(unknown), (unknown), Karsten Schrör, Peter Heering	9
11	Reduction of Infarct Size by Selective Stimulation of Prostaglandin EP3Receptors in the Reperfused Ischemic Pig Heart 2000 ·Journal of Molecular and Cellular Cardiology ·Thomas Hohlfeld, Jutta Meyer-Kirchrath, (unknown), Karsten Schrör	40
12	Interaction of adenosine and prostacyclin in coronary flow regulation after myocardial ischemia 1999 ·European Journal of Pharmacology ·Verena Stangl, (unknown), Karsten Schrör, Karl Stangl, Gert Baumann, Stephan B. Felix	1
13	Klinische Pharmakologie von Acetylsalizylsäure 1992 ·Zeitschrift für Kardiologie ·H. Schröder, Karsten Schrör	6
14	Oral Cicaprost Protects from Hypercholesterolaemia-Induced Impairment of Coronary Vasodilation 1992 ·Birkhäuser Basel eBooks ·(unknown), Thomas Hohlfeld, H. Strobach, Karsten Schrör	5
15	PGD2 and its mimetic ZK 110.841 are potent inhibitors of receptor-mediated activation of human neutrophils. 1991 ·PubMed ·(unknown), Karsten Schrör	23
16	ADP-induced second wave aggregation in platelet rich plasma from hypercholesterolemic rabbits 1991 ·Thrombosis Research ·A.-A. Weber, (unknown), Karsten Schrör	15
17	Nitric oxide is the endothelium-derived relaxing factor in bovine pial arterioles. 1990 ·PubMed ·(unknown), Karsten Schrör	10
18	Cyclic GMP mediates SIN-1-induced inhibition of human polymorphonuclear leukocytes 1990 ·European Journal of Pharmacology ·H. Schröder, Peter Ney, (unknown), Karsten Schrör	57
19	Arterial wall regeneration in small-caliber vascular grafts in rats 1985 ·Journal of Thoracic and Cardiovascular Surgery ·Berend van der Lei, Harald Darius, Karsten Schrör, Paul Nieuwenhuis, I. Quintus Molenaar, Charles R.H. Wildevuur	33
20	Plasma exchanges in frequently recurrent hemolytic-uremic syndrome in a child. 1983 ·PubMed ·(unknown), (unknown), (unknown), Karsten Schrör	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact